Steris (STE) Research & Development (2018 - 2026)

Steris' Research & Development history runs 9 years deep, the most recent figure standing at $28.8 million for Q1 2026.

• On a quarterly basis, Research & Development rose 4.35% year-over-year to $28.8 million in Q1 2026; TTM through Mar 2026 was $112.9 million, a 4.93% increase from a year earlier, with the FY2026 full-year figure at $112.9 million, up 4.93% from the prior year.
• Research & Development fell to $28.8 million in Q1 2026 per STE's latest filing, from $29.5 million in the prior quarter.
• Across five years, Research & Development topped out at $29.5 million in Q4 2025 and bottomed at $23.3 million in Q1 2023.
• The 5-year median for Research & Development is $26.3 million (2023), against an average of $26.3 million.
• Across the five-year window, Research & Development jumped 41.69% in 2022 and fell 6.17% in 2023, its largest moves.
• Year by year, Research & Development stood at $25.5 million in 2022, then fell by 1.02% to $25.3 million in 2023, then advanced by 8.49% to $27.4 million in 2024, then grew by 7.66% to $29.5 million in 2025, then declined by 2.37% to $28.8 million in 2026.
• Per Business Quant, the three latest STE Research & Development figures stand at $28.8 million (Q1 2026), $29.5 million (Q4 2025), and $28.2 million (Q3 2025).